Lyka Labs informs about unaudited financial results

13 Feb 2018 Evaluate

Lyka Labs has informed about Un-audited Standalone Financial Results of the Company for the Third Quarter ended December 31, 2017 which were taken on record by the Board of Directors at its meeting held today together with Limited Review Report by Auditors.

The above information is a part of company’s filings submitted to BSE.


Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×